Enteral Feeding Formulas Market by Type (Polymeric Formulas, Monomeric Formulas, Blenderized Foods, Formulas for Specific Metabolic Needs, Immune Enhancing Formulas, Modular Formulas, Hydration Solutions); by Stage (Adult, Children); By Application (Oncology, Gastroenterology, Neurology, Diabetes, Others); by End Users (Hospitals, Long-Term Care { Nursing Homes, Homecare Agencies, Assisted Living Facilities}); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Supply, Demand, Comparative Analysis, Trends and Forecast, 2018-2026
Industry Trends
Nutritional support is considered as a vital component in medical care. Enteral nutrition (EN) is provision of nutrients via the gastrointestinal (GI) tract through a feeding tube, catheter or stoma. It is the preferred route for the provision of nutrition for patients who cannot meet their nutrition needs through voluntary oral intake. This type of feeding provides many physiologic, metabolic, safety, and cost benefits over other methods of feeding. Enteral nutrition is preferred as a route of administration for nutritional support when gastrointestinal tract is functional. Compared to the conventional central venous feeding, enteral feeding is associated with fewer serious complications. It helps in better nutrient absorption and facilitates better metabolic activities. In addition, delivery of nutrients by GI tract allows decreased risk of septic, risk of cholestasis and stimulates dozens of gut peptides. Although enteral feeding techniques existed since ancient times, most of the developments in enteral feeding techniques took place during the 20th century. Commercial products with chemically defined feeding formulas were introduced in 1950s, while the development of modern formulas took place in 1970s.
Enteral Feeding Formulas Market, By Region, 2018 – 2026, (USD Million)
The selection of an enteral formula must be patient specific. The functioning and capacity of the GI tract, underlying disease states and patient tolerance must be assessed to determine which formula should be selected. In terms of revenue, the global enteral feeding formulas market was US$ 4680 Mn in 2017 and is estimated to be US$ 6710 Mn by 2022.
Enteral Feeding Formulas Market, by Stage
At present, the adult sub segment is leading the market. Enteral nutrition in adults is prescribed when an individual is not capable for oral intake of food. For instance, in dysphagia or reduced level of consciousness, oral intake is not adequate to meet nutritional requirements in adults. At that time, enteral nutrition has proved to be safe, cost effective, and compatible with the body’s normal processes. Enteral feeding formulas are used in adults suffering from various health related conditions. They are used for patients suffering from severe acute pancreatitis, high output proximal fistula, intractable vomiting or diarrhea and others. Many a times due to major injuries, individuals get bedridden. Even if an individual undergoes major surgeries of throat and stomach lining, he is not allowed to consume food orally. At, such times eternal feeding formulas are prescribed by doctors.
Enteral Feeding Formulas Market, by Region
The region of North America is on the forefront as compared to others during the forecast year 2018-2026, owing to increasing number of citizens residing in the United States, suffering from severe esophagus related conditions and widespread awareness about enteral feeding devices. The American Cancer Society estimated that people suffering from esophageal cancer in the United States for the year 2018 is 17,290. The number has been increasing since 2010. The affected people are mostly advised to opt for enteral feeding as their digestion system remains weak which restricts them from taking anything orally.
Competitive Landscape
The enteral feeding formulas market report provides both, qualitative and quantitative research of the market, as well as strategic insights along with developments that are being adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisition (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their manufacturing base, competitors, product type, application and specification, pricing, and gross margin.
Enteral feeding formulas market participants include Nestlé S.A., Mead Johnson & Company, LLC, Danone S.A., Fresenius Kabi A, B. Braun Melsungen AG, Global Health Products, Inc., Victus, Inc., Abbott Laboratories, Meiji Holdings Co., Ltd, Hormel Foods, LLC, Byram Healthcare, Medline Industries Inc, Nutritional Medicinals, LLC, NUTRICIA, Real Food Blends, HOIL BIOMAED INC. amongst others. Nestlé Health Science announced the launch of its new and improved product ‘Compleat’ family of tube-feeding formulas for adults and children in 2017. The improved product now includes a variety of ingredients from real foods, vitamins, minerals, and other nutrients.
Enteral Feeding Formulas Market Background
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Methodology
1.4. Assumptions
2. Enteral Feeding Formulas Market Snapshot
3. Executive Summary: Enteral Feeding Formulas Market
4. Qualitative Analysis: Enteral Feeding Formulas Market
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Development
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Trends in Market
5. Global Enteral Feeding Formulas Market Analysis and
Forecasts, 2018 – 2026
5.1. Overview
5.1.1. Global Market Revenue (US$ Mn) and Forecasts
5.2. Global Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
5.2.1. Polymeric Formulas
5.2.1.1. Definition
5.2.1.2. Market Penetration
5.2.1.3. Market Revenue Expected to Increase by 2026
5.2.1.4. Compound Annual Growth Rate (CAGR)
5.2.2. Monomeric Formulas
5.2.2.1. Definition
5.2.2.2. Market Penetration
5.2.2.3. Market Revenue Expected to Increase by 2026
5.2.2.4. Compound Annual Growth Rate (CAGR)
5.2.3. Blenderized Foods
5.2.3.1. Definition
5.2.3.2. Market Penetration
5.2.3.3. Market Revenue Expected to Increase by 2026
5.2.3.4. Compound Annual Growth Rate (CAGR)
5.2.4. Formulas for Specific Metabolic Needs
5.2.4.1. Definition
5.2.4.2. Market Penetration
5.2.4.3. Market Revenue Expected to Increase by 2026
5.2.4.4. Compound Annual Growth Rate (CAGR)
5.2.5. Immune Enhancing Formulas
5.2.5.1. Definition
5.2.5.2. Market Penetration
5.2.5.3. Market Revenue Expected to Increase by 2026
5.2.5.4. Compound Annual Growth Rate (CAGR)
5.2.6. Modular Formulas
5.2.6.1. Definition
5.2.6.2. Market Penetration
5.2.6.3. Market Revenue Expected to Increase by 2026
5.2.6.4. Compound Annual Growth Rate (CAGR)
5.2.7. Hydration Solutions
5.2.7.1. Definition
5.2.7.2. Market Penetration
5.2.7.3. Market Revenue Expected to Increase by 2026
5.2.7.4. Compound Annual Growth Rate (CAGR)
5.3. Key Segment for Channeling Investments
5.3.1. By Type
6. Global Enteral Feeding Formulas Market Analysis and
Forecasts, 2018 – 2026
6.1. Overview
6.2. Global Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Stage
6.2.1. Adult
6.2.1.1. Definition
6.2.1.2. Market Penetration
6.2.1.3. Market Revenue Expected to Increase by 2026
6.2.1.4. Compound Annual Growth Rate (CAGR)
6.2.2. Children
6.2.2.1. Definition
6.2.2.2. Market Penetration
6.2.2.3. Market Revenue Expected to Increase by 2026
6.2.2.4. Compound Annual Growth Rate (CAGR)
6.3. Key Segment for Channeling Investments
6.3.1. By Stage
7. Global Enteral Feeding Formulas Market Analysis and
Forecasts, 2018 – 2026
7.1. Overview
7.2. Global Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Application
7.2.1. Oncology
7.2.1.1. Definition
7.2.1.2. Market Penetration
7.2.1.3. Market Revenue Expected to Increase by 2026
7.2.1.4. Compound Annual Growth Rate (CAGR)
7.2.2. Gastroenterology
7.2.2.1. Definition
7.2.2.2. Market Penetration
7.2.2.3. Market Revenue Expected to Increase by 2026
7.2.2.4. Compound Annual Growth Rate (CAGR)
7.2.3. Neurology
7.2.3.1. Definition
7.2.3.2. Market Penetration
7.2.3.3. Market Revenue Expected to Increase by 2026
7.2.3.4. Compound Annual Growth Rate (CAGR)
7.2.4. Diabetes
7.2.4.1. Definition
7.2.4.2. Market Penetration
7.2.4.3. Market Revenue Expected to Increase by 2026
7.2.4.4. Compound Annual Growth Rate (CAGR)
7.2.5. Others
7.2.5.1. Definition
7.2.5.2. Market Penetration
7.2.5.3. Market Revenue Expected to Increase by 2026
7.2.5.4. Compound Annual Growth Rate (CAGR)
7.3. Key Segment for Channeling Investments
7.3.1. By Application
8. Global Enteral Feeding Formulas Market Analysis and
Forecasts, 2018 – 2026
8.1. Overview
8.2. Global Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
8.2.1. Hospitals
8.2.1.1. Definition
8.2.1.2. Market Penetration
8.2.1.3. Market Revenue Expected to Increase by 2026
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.2. Long-Term Care
(Definition, Market Penetration, Market Revenue Expected to Increase by 2026,
Compound Annual Growth Rate (CAGR) and information on Nursing Homes, Homecare
Agencies, Assisted Living Facilities)
8.2.2.1. Nursing Homes
8.2.2.2. Homecare Agencies
8.2.2.3. Assisted Living Facilities
8.3. Key Segment for Channeling Investments
8.3.1. By End Users
9. North America Enteral Feeding Formulas Market Analysis and
Forecasts, 2018 – 2026
9.1. Overview
9.1.1. North America Market Revenue (US$ Mn)
9.2. North America Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Type
9.2.1. Polymeric Formulas
9.2.2. Monomeric Formulas
9.2.3. Blenderized Foods
9.2.4. Formulas for Specific Metabolic Needs
9.2.5. Immune Enhancing Formulas
9.2.6. Modular Formulas
9.2.7. Hydration Solutions
9.3. North America Market Revenue (US$ Mn) and Forecasts, By Stage
9.3.1. Adult
9.3.2. Children
9.4. North America Market Revenue (US$ Mn) and Forecasts, By
Application
9.4.1. Oncology
9.4.2. Gastroenterology
9.4.3. Neurology
9.4.4. Diabetes
9.4.5. Others
9.5. North America Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By End Users
9.5.1. Hospitals
9.5.2. Long-Term Care
9.5.2.1. Nursing Homes
9.5.2.2. Homecare Agencies
9.5.2.3. Assisted Living Facilities
9.6. North America Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Country
9.6.1. U.S.
9.6.1.1. U.S. Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
9.6.1.1.1. Polymeric Formulas
9.6.1.1.2. Monomeric Formulas
9.6.1.1.3. Blenderized Foods
9.6.1.1.4. Formulas for Specific Metabolic Needs
9.6.1.1.5. Immune Enhancing Formulas
9.6.1.1.6. Modular Formulas
9.6.1.1.7. Hydration Solutions
9.6.1.2. U.S. Market Revenue (US$ Mn) and Forecasts, By Stage
9.6.1.2.1. Adult
9.6.1.2.2. Children
9.6.1.3. U.S. Market Revenue (US$ Mn) and Forecasts, By Application
9.6.1.3.1. Oncology
9.6.1.3.2. Gastroenterology
9.6.1.3.3. Neurology
9.6.1.3.4. Diabetes
9.6.1.3.5. Others
9.6.1.4. U.S. Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
9.6.1.4.1. Hospitals
9.6.1.4.2. Long-Term Care
9.6.1.4.2.1. Nursing Homes
9.6.1.4.2.2. Homecare Agencies
9.6.1.4.2.3. Assisted Living Facilities
9.6.2. Rest of North America
9.6.2.1. Rest of North America Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By Type
9.6.2.1.1. Polymeric Formulas
9.6.2.1.2. Monomeric Formulas
9.6.2.1.3. Blenderized Foods
9.6.2.1.4. Formulas for Specific Metabolic Needs
9.6.2.1.5. Immune Enhancing Formulas
9.6.2.1.6. Modular Formulas
9.6.2.1.7. Hydration Solutions
9.6.2.2. Rest of North America Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By Stage
9.6.2.2.1. Adult
9.6.2.2.2. Children
9.6.2.3. Rest of North America Market Revenue (US$ Mn) and Forecasts,
By Application
9.6.2.3.1. Oncology
9.6.2.3.2. Gastroenterology
9.6.2.3.3. Neurology
9.6.2.3.4. Diabetes
9.6.2.3.5. Others
9.6.2.4. Rest of North America Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By End Users
9.6.2.4.1. Hospitals
9.6.2.4.2. Long-Term Care
9.6.2.4.2.1. Nursing Homes
9.6.2.4.2.2. Homecare Agencies
9.6.2.4.2.3. Assisted Living Facilities
9.7. Key Segment for Channeling Investments
9.7.1. By Country
9.7.2. By Type
9.7.3. By Stage
9.7.4. By Application
9.7.5. By End Users
10. Europe Enteral Feeding Formulas Market Analysis and
Forecasts, 2018 – 2026
10.1. Overview
10.1.1. Europe Market Revenue (US$ Mn)
10.2. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
10.2.1. Polymeric Formulas
10.2.2. Monomeric Formulas
10.2.3. Blenderized Foods
10.2.4. Formulas for Specific Metabolic Needs
10.2.5. Immune Enhancing Formulas
10.2.6. Modular Formulas
10.2.7. Hydration Solutions
10.3. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Stage
10.3.1. Adult
10.3.2. Children
10.4. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Application
10.4.1. Oncology
10.4.2. Gastroenterology
10.4.3. Neurology
10.4.4. Diabetes
10.4.5. Others
10.5. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
10.5.1. Hospitals
10.5.2. Long-Term Care
10.5.2.1. Nursing Homes
10.5.2.2. Homecare Agencies
10.5.2.3. Assisted Living Facilities
10.6. Europe Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Country
10.6.1. France
10.6.1.1. France Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.1.1.1. Polymeric Formulas
10.6.1.1.2. Monomeric Formulas
10.6.1.1.3. Blenderized Foods
10.6.1.1.4. Formulas for Specific Metabolic Needs
10.6.1.1.5. Immune Enhancing Formulas
10.6.1.1.6. Modular Formulas
10.6.1.1.7. Hydration Solutions
10.6.1.2. France Market Revenue (US$ Mn) and Forecasts, By Stage
10.6.1.2.1. Adult
10.6.1.2.2. Children
10.6.1.3. France Market Revenue (US$ Mn) and Forecasts, By Application
10.6.1.3.1. Oncology
10.6.1.3.2. Gastroenterology
10.6.1.3.3. Neurology
10.6.1.3.4. Diabetes
10.6.1.3.5. Others
10.6.1.4. France Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
10.6.1.4.1. Hospitals
10.6.1.4.2. Long-Term Care
10.6.1.4.2.1. Nursing Homes
10.6.1.4.2.2. Homecare Agencies
10.6.1.4.2.3. Assisted Living Facilities
10.6.2. The UK
10.6.2.1. The UK Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.2.1.1. Polymeric Formulas
10.6.2.1.2. Monomeric Formulas
10.6.2.1.3. Blenderized Foods
10.6.2.1.4. Formulas for Specific Metabolic Needs
10.6.2.1.5. Immune Enhancing Formulas
10.6.2.1.6. Modular Formulas
10.6.2.1.7. Hydration Solutions
10.6.2.2. The UK Market Revenue (US$ Mn) and Forecasts, By Stage
10.6.2.2.1. Adult
10.6.2.2.2. Children
10.6.2.3. The UK Market Revenue (US$ Mn) and Forecasts, By Application
10.6.2.3.1. Oncology
10.6.2.3.2. Gastroenterology
10.6.2.3.3. Neurology
10.6.2.3.4. Diabetes
10.6.2.3.5. Others
10.6.2.4. The UK Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
10.6.2.4.1. Hospitals
10.6.2.4.2. Long-Term Care
10.6.2.4.2.1.
Nursing Homes
10.6.2.4.2.2.
Homecare Agencies
10.6.2.4.2.3.
Assisted Living
Facilities
10.6.3. Spain
10.6.3.1. Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and Forecasts,
By Type
10.6.3.1.1. Polymeric Formulas
10.6.3.1.2. Monomeric Formulas
10.6.3.1.3. Blenderized Foods
10.6.3.1.4. Formulas for Specific Metabolic Needs
10.6.3.1.5. Immune Enhancing Formulas
10.6.3.1.6. Modular Formulas
10.6.3.1.7. Hydration Solutions
10.6.3.2. Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Stage
10.6.3.2.1. Adult
10.6.3.2.2. Children
10.6.3.3. Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.3.3.1. Oncology
10.6.3.3.2. Gastroenterology
10.6.3.3.3. Neurology
10.6.3.3.4. Diabetes
10.6.3.3.5. Others
10.6.3.4. Spain Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
10.6.3.4.1. Hospitals
10.6.3.4.2. Long-Term Care
10.6.3.4.2.1.
Nursing Homes
10.6.3.4.2.2.
Homecare Agencies
10.6.3.4.2.3. Assisted Living Facilities
10.6.4. Germany
10.6.4.1. Germany Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.4.1.1. Polymeric Formulas
10.6.4.1.2. Monomeric Formulas
10.6.4.1.3. Blenderized Foods
10.6.4.1.4. Formulas for Specific Metabolic Needs
10.6.4.1.5. Immune Enhancing Formulas
10.6.4.1.6. Modular Formulas
10.6.4.1.7. Hydration Solutions
10.6.4.2. Germany Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Stage
10.6.4.2.1. Adult
10.6.4.2.2. Children
10.6.4.3. Germany Market Revenue (US$ Mn) and Forecasts, By Application
10.6.4.3.1. Oncology
10.6.4.3.2. Gastroenterology
10.6.4.3.3. Neurology
10.6.4.3.4. Diabetes
10.6.4.3.5. Others
10.6.4.4. Germany Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
10.6.4.4.1. Hospitals
10.6.4.4.2. Long-Term Care
10.6.4.4.2.1.
Nursing Homes
10.6.4.4.2.2.
Homecare Agencies
10.6.4.4.2.3. Assisted Living Facilities
10.6.5. Italy
10.6.5.1. Italy Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
10.6.5.1.1. Polymeric Formulas
10.6.5.1.2. Monomeric Formulas
10.6.5.1.3. Blenderized Foods
10.6.5.1.4. Formulas for Specific Metabolic Needs
10.6.5.1.5. Immune Enhancing Formulas
10.6.5.1.6. Modular Formulas
10.6.5.1.7. Hydration Solutions
10.6.5.2. Italy Market Revenue (US$ Mn) and Forecasts, By Stage
10.6.5.2.1. Adult
10.6.5.2.2. Children
10.6.5.3. Italy Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Application
10.6.5.3.1. Oncology
10.6.5.3.2. Gastroenterology
10.6.5.3.3. Neurology
10.6.5.3.4. Diabetes
10.6.5.3.5. Others
10.6.5.4. Italy Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.5.4.1. Hospitals
10.6.5.4.2. Long-Term Care
10.6.5.4.2.1.
Nursing Homes
10.6.5.4.2.2.
Homecare Agencies
10.6.5.4.2.3.
Assisted Living
Facilities
10.6.6. Rest of Europe
10.6.6.1. Rest of Europe Enteral Feeding Formulas Market Revenue (US$
Mn) and Forecasts, By Type
10.6.6.1.1. Polymeric Formulas
10.6.6.1.2. Monomeric Formulas
10.6.6.1.3. Blenderized Foods
10.6.6.1.4. Formulas for Specific Metabolic Needs
10.6.6.1.5. Immune Enhancing Formulas
10.6.6.1.6. Modular Formulas
10.6.6.1.7. Hydration Solutions
10.6.6.2. Rest of Europe Enteral Feeding Formulas Market Revenue (US$
Mn) and Forecasts, By Stage
10.6.6.2.1. Adult
10.6.6.2.2. Children
10.6.6.3. Rest of Europe Market Revenue (US$ Mn) and Forecasts, By
Application
10.6.6.3.1. Oncology
10.6.6.3.2. Gastroenterology
10.6.6.3.3. Neurology
10.6.6.3.4. Diabetes
10.6.6.3.5. Others
10.6.6.4. Rest of Europe Market Revenue (US$ Mn) and Forecasts, By End
Users
10.6.6.4.1. Hospitals
10.6.6.4.2. Long-Term Care
10.6.6.4.2.1.
Nursing Homes
10.6.6.4.2.2.
Homecare Agencies
10.6.6.4.2.3.
Assisted Living
Facilities
10.7. Key Segment for Channeling Investments
10.7.1. By Country
10.7.2. By Type
10.7.3. By Stage
10.7.4. By Application
10.7.5. By End Users
11. Asia Pacific Enteral
Feeding Formulas Market Analysis and Forecasts, 2018 – 2026
11.1. Overview
11.1.1. Asia Pacific Market Revenue (US$ Mn)
11.2. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Type
11.2.1. Polymeric Formulas
11.2.2. Monomeric Formulas
11.2.3. Blenderized Foods
11.2.4. Formulas for Specific Metabolic Needs
11.2.5. Immune Enhancing Formulas
11.2.6. Modular Formulas
11.2.7. Hydration Solutions
11.3. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Stage
11.3.1. Adult
11.3.2. Children
11.4. Asia Pacific Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.1. Oncology
11.4.2. Gastroenterology
11.4.3. Neurology
11.4.4. Diabetes
11.4.5. Others
11.5. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By End Users
11.5.1. Hospitals
11.5.2. Long-Term Care
11.5.2.1. Nursing Homes
11.5.2.2. Homecare Agencies
11.5.2.3. Assisted Living Facilities
11.6. Asia Pacific Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Country
11.6.1. China
11.6.1.1. China Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.1.1.1. Polymeric Formulas
11.6.1.1.2. Monomeric Formulas
11.6.1.1.3. Blenderized Foods
11.6.1.1.4. Formulas for Specific Metabolic Needs
11.6.1.1.5. Immune Enhancing Formulas
11.6.1.1.6. Modular Formulas
11.6.1.1.7. Hydration Solutions
11.6.1.2. China Market Revenue (US$ Mn) and Forecasts, By Stage
11.6.1.2.1. Adult
11.6.1.2.2. Children
11.6.1.3. China Market Revenue (US$ Mn) and Forecasts, By Application
11.6.1.3.1. Oncology
11.6.1.3.2. Gastroenterology
11.6.1.3.3. Neurology
11.6.1.3.4. Diabetes
11.6.1.3.5. Others
11.6.1.4. China Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
11.6.1.4.1. Hospitals
11.6.1.4.2. Long-Term Care
11.6.1.4.2.1.
Nursing Homes
11.6.1.4.2.2.
Homecare Agencies
11.6.1.4.2.3.
Assisted Living
Facilities
11.6.2. Japan
11.6.2.1. Japan Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.2.1.1. Polymeric Formulas
11.6.2.1.2. Monomeric Formulas
11.6.2.1.3. Blenderized Foods
11.6.2.1.4. Formulas for Specific Metabolic Needs
11.6.2.1.5. Immune Enhancing Formulas
11.6.2.1.6. Modular Formulas
11.6.2.1.7. Hydration Solutions
11.6.2.2. Japan Market Revenue (US$ Mn) and Forecasts, By Stage
11.6.2.2.1. Adult
11.6.2.2.2. Children
11.6.2.3. Japan Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.2.3.1. Oncology
11.6.2.3.2. Gastroenterology
11.6.2.3.3. Neurology
11.6.2.3.4. Diabetes
11.6.2.3.5. Others
11.6.2.4. Japan Market Revenue (US$ Mn) and Forecasts, By End Users
11.6.2.4.1. Hospitals
11.6.2.4.2. Long-Term Care
11.6.2.4.2.1.
Nursing Homes
11.6.2.4.2.2.
Homecare Agencies
11.6.2.4.2.3. Assisted Living Facilities
11.6.3. India
11.6.3.1. India Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
11.6.3.1.1. Polymeric Formulas
11.6.3.1.2. Monomeric Formulas
11.6.3.1.3. Blenderized Foods
11.6.3.1.4. Formulas for Specific Metabolic Needs
11.6.3.1.5. Immune Enhancing Formulas
11.6.3.1.6. Modular Formulas
11.6.3.1.7. Hydration Solutions
11.6.3.2. India Market Revenue (US$ Mn) and Forecasts, By Stage
11.6.3.2.1. Adult
11.6.3.2.2. Children
11.6.3.3. India Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Application
11.6.3.3.1. Oncology
11.6.3.3.2. Gastroenterology
11.6.3.3.3. Neurology
11.6.3.3.4. Diabetes
11.6.3.3.5. Others
11.6.3.4. India Market Revenue (US$ Mn) and Forecasts, By End Users
11.6.3.4.1. Hospitals
11.6.3.4.2. Long-Term Care
11.6.3.4.2.1.
Nursing Homes
11.6.3.4.2.2.
Homecare Agencies
11.6.3.4.2.3.
Assisted Living
Facilities
11.6.4. Southeast Asia
11.6.4.1. Southeast Asia Enteral Feeding Formulas Market Revenue (US$
Mn) and Forecasts, By Type
11.6.4.1.1. Polymeric Formulas
11.6.4.1.2. Monomeric Formulas
11.6.4.1.3. Blenderized Foods
11.6.4.1.4. Formulas for Specific Metabolic Needs
11.6.4.1.5. Immune Enhancing Formulas
11.6.4.1.6. Modular Formulas
11.6.4.1.7. Hydration Solutions
11.6.4.2. Southeast Asia Market Revenue (US$ Mn) and Forecasts, By Stage
11.6.4.2.1. Adult
11.6.4.2.2. Children
11.6.4.3. Southeast Asia Enteral Feeding Formulas Market Revenue (US$
Mn) and Forecasts, By Application
11.6.4.3.1. Oncology
11.6.4.3.2. Gastroenterology
11.6.4.3.3. Neurology
11.6.4.3.4. Diabetes
11.6.4.3.5. Others
11.6.4.4. Southeast Asia Market Revenue (US$ Mn) and Forecasts, By End
Users
11.6.4.4.1. Hospitals
11.6.4.4.2. Long-Term Care
11.6.4.4.2.1.
Nursing Homes
11.6.4.4.2.2.
Homecare Agencies
11.6.4.4.2.3.
Assisted Living
Facilities
11.6.5. Rest of Asia Pacific
11.6.5.1. Rest of Asia Pacific Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By Type
11.6.5.1.1. Polymeric Formulas
11.6.5.1.2. Monomeric Formulas
11.6.5.1.3. Blenderized Foods
11.6.5.1.4. Formulas for Specific Metabolic Needs
11.6.5.1.5. Immune Enhancing Formulas
11.6.5.1.6. Modular Formulas
11.6.5.1.7. Hydration Solutions
11.6.5.2. Rest of Asia Pacific Market Revenue (US$ Mn) and Forecasts, By
Stage
11.6.5.2.1. Adult
11.6.5.2.2. Children
11.6.5.3. Rest of Asia Pacific Market Revenue (US$ Mn) and Forecasts, By
Application
11.6.5.3.1. Oncology
11.6.5.3.2. Gastroenterology
11.6.5.3.3. Neurology
11.6.5.3.4. Diabetes
11.6.5.3.5. Others
11.6.5.4. Rest of Asia Pacific Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By End Users
11.6.5.4.1. Hospitals
11.6.5.4.2. Long-Term Care
11.6.5.4.2.1.
Nursing Homes
11.6.5.4.2.2.
Homecare Agencies
11.6.5.4.2.3. Assisted Living Facilities
11.7. Key Segment for Channeling Investments
11.7.1. By Country
11.7.2. By Type
11.7.3. By Stage
11.7.4. By Application
11.7.5. By End Users
12. Middle East and Africa Enteral Feeding Formulas Market
Analysis and Forecasts, 2018 – 2026
12.1. Overview
12.1.1. Middle East and Africa Market Revenue (US$ Mn)
12.2. Middle East and Africa Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By Type
12.2.1. Polymeric Formulas
12.2.2. Monomeric Formulas
12.2.3. Blenderized Foods
12.2.4. Formulas for Specific Metabolic Needs
12.2.5. Immune Enhancing Formulas
12.2.6. Modular Formulas
12.2.7. Hydration Solutions
12.3. Middle East and Africa Market Revenue (US$ Mn) and Forecasts,
By Stage
12.3.1. Adult
12.3.2. Children
12.4. Middle East and Africa Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.1. Oncology
12.4.2. Gastroenterology
12.4.3. Neurology
12.4.4. Diabetes
12.4.5. Others
12.5. Middle East and Africa Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By End Users
12.5.1. Hospitals
12.5.2. Long-Term Care
12.5.2.1. Nursing Homes
12.5.2.2. Homecare Agencies
12.5.2.3. Assisted Living Facilities
12.6. Middle East and Africa Market Revenue (US$ Mn) and Forecasts,
By Country
12.6.1. GCC Countries
12.6.1.1. GCC Countries Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Type
12.6.1.1.1. Polymeric Formulas
12.6.1.1.2. Monomeric Formulas
12.6.1.1.3. Blenderized Foods
12.6.1.1.4. Formulas for Specific Metabolic Needs
12.6.1.1.5. Immune Enhancing Formulas
12.6.1.1.6. Modular Formulas
12.6.1.1.7. Hydration Solutions
12.6.1.2. GCC Countries Market Revenue (US$ Mn) and Forecasts, By Stage
12.6.1.2.1. Adult
12.6.1.2.2. Children
12.6.1.3. GCC Countries Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.1.3.1. Oncology
12.6.1.3.2. Gastroenterology
12.6.1.3.3. Neurology
12.6.1.3.4. Diabetes
12.6.1.3.5. Others
12.6.1.4. GCC Countries Market Revenue (US$ Mn) and Forecasts, By End
Users
12.6.1.4.1. Hospitals
12.6.1.4.2. Long-Term Care
12.6.1.4.2.1.
Nursing Homes
12.6.1.4.2.2.
Homecare Agencies
12.6.1.4.2.3.
Assisted Living
Facilities
12.6.2. Southern Africa
12.6.2.1. Southern Africa Enteral Feeding Formulas Market Revenue (US$
Mn) and Forecasts, By Type
12.6.2.1.1. Polymeric Formulas
12.6.2.1.2. Monomeric Formulas
12.6.2.1.3. Blenderized Foods
12.6.2.1.4. Formulas for Specific Metabolic Needs
12.6.2.1.5. Immune Enhancing Formulas
12.6.2.1.6. Modular Formulas
12.6.2.1.7. Hydration Solutions
12.6.2.2. Southern Africa Market Revenue (US$ Mn) and Forecasts, By
Stage
12.6.2.2.1. Adult
12.6.2.2.2. Children
12.6.2.3. Southern Africa Enteral Feeding Formulas Market Revenue (US$
Mn) and Forecasts, By Application
12.6.2.3.1. Oncology
12.6.2.3.2. Gastroenterology
12.6.2.3.3. Neurology
12.6.2.3.4. Diabetes
12.6.2.3.5. Others
12.6.2.4. Southern Africa Enteral Feeding Formulas Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.2.4.1. Hospitals
12.6.2.4.2. Long-Term Care
12.6.2.4.2.1.
Nursing Homes
12.6.2.4.2.2.
Homecare Agencies
12.6.2.4.2.3.
Assisted Living
Facilities
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Type
12.6.3.1.1. Polymeric Formulas
12.6.3.1.2. Monomeric Formulas
12.6.3.1.3. Blenderized Foods
12.6.3.1.4. Formulas for Specific Metabolic Needs
12.6.3.1.5. Immune Enhancing Formulas
12.6.3.1.6. Modular Formulas
12.6.3.1.7. Hydration Solutions
12.6.3.2. Rest of MEA Market Revenue (US$ Mn) and Forecasts, By Stage
12.6.3.2.1. Adult
12.6.3.2.2. Children
12.6.3.3. Rest of MEA Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Application
12.6.3.3.1. Oncology
12.6.3.3.2. Gastroenterology
12.6.3.3.3. Neurology
12.6.3.3.4. Diabetes
12.6.3.3.5. Others
12.6.3.4. Rest of MEA Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By End Users
12.6.3.4.1. Hospitals
12.6.3.4.2. Long-Term Care
12.6.3.4.2.1.
Nursing Homes
12.6.3.4.2.2.
Homecare Agencies
12.6.3.4.2.3.
Assisted Living
Facilities
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Type
12.7.3. By Stage
12.7.4. By Application
12.7.5. By End Users
13. Latin America Enteral Feeding Formulas Market Analysis and
Forecasts, 2018 – 2026
13.1. Overview
13.1.1. Latin America Market Revenue (US$ Mn)
13.2. Latin America Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By Type
13.2.1. Polymeric Formulas
13.2.2. Monomeric Formulas
13.2.3. Blenderized Foods
13.2.4. Formulas for Specific Metabolic Needs
13.2.5. Immune Enhancing Formulas
13.2.6. Modular Formulas
13.2.7. Hydration Solutions
13.3. Latin America Market Revenue (US$ Mn) and Forecasts, By Stage
13.3.1. Adult
13.3.2. Children
13.4. Latin America Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.1. Oncology
13.4.2. Gastroenterology
13.4.3. Neurology
13.4.4. Diabetes
13.4.5. Others
13.5. Latin America Enteral Feeding Formulas Market Revenue (US$ Mn)
and Forecasts, By End Users
13.5.1. Hospitals
13.5.2. Long-Term Care
13.5.2.1. Nursing Homes
13.5.2.2. Homecare Agencies
13.5.2.3. Assisted Living Facilities
13.6. Latin America Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.1. Brazil
13.6.1.1. Brazil Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.1.1.1. Polymeric Formulas
13.6.1.1.2. Monomeric Formulas
13.6.1.1.3. Blenderized Foods
13.6.1.1.4. Formulas for Specific Metabolic Needs
13.6.1.1.5. Immune Enhancing Formulas
13.6.1.1.6. Modular Formulas
13.6.1.1.7. Hydration Solutions
13.6.1.2. Brazil Market Revenue (US$ Mn) and Forecasts, By Stage
13.6.1.2.1. Adult
13.6.1.2.2. Children
13.6.1.3. Brazil Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.3.1. Oncology
13.6.1.3.2. Gastroenterology
13.6.1.3.3. Neurology
13.6.1.3.4. Diabetes
13.6.1.3.5. Others
13.6.1.4. Brazil Enteral Feeding Formulas Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.1.4.1. Hospitals
13.6.1.4.2. Long-Term Care
13.6.1.4.2.1.
Nursing Homes
13.6.1.4.2.2.
Homecare Agencies
13.6.1.4.2.3.
Assisted Living
Facilities
13.6.2. Rest of Latin America
13.6.2.1. Rest of Latin America Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By Type
13.6.2.1.1. Polymeric Formulas
13.6.2.1.2. Monomeric Formulas
13.6.2.1.3. Blenderized Foods
13.6.2.1.4. Formulas for Specific Metabolic Needs
13.6.2.1.5. Immune Enhancing Formulas
13.6.2.1.6. Modular Formulas
13.6.2.1.7. Hydration Solutions
13.6.2.2. Rest of Latin America Market Revenue (US$ Mn) and Forecasts,
By Stage
13.6.2.2.1. Adult
13.6.2.2.2. Children
13.6.2.3. Rest of Latin America Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.2.3.1. Oncology
13.6.2.3.2. Gastroenterology
13.6.2.3.3. Neurology
13.6.2.3.4. Diabetes
13.6.2.3.5. Others
13.6.2.4. Rest of Latin America Enteral Feeding Formulas Market Revenue
(US$ Mn) and Forecasts, By End Users
13.6.2.4.1. Hospitals
13.6.2.4.2. Long-Term Care
13.6.2.4.2.1.
Nursing Homes
13.6.2.4.2.2.
Homecare Agencies
13.6.2.4.2.3. Assisted Living Facilities
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Type
13.7.3. By Stage
13.7.4. By Application
13.7.5. By End Users
14. Competitive Benchmarking
14.1. Player Positioning Analysis
14.2. Global Presence and Growth Strategies
15. Player Profiles
15.1. Abbott Laboratories
15.1.1. Company Details
15.1.2. Company Overview
15.1.3. Product Offerings
15.1.4. Key Developments
15.1.5. Financial Analysis
15.1.6. SWOT Analysis
15.1.7. Business Strategies
15.2. B. Braun Melsungen AG
15.2.1. Company Details
15.2.2. Company Overview
15.2.3. Product Offerings
15.2.4. Key Developments
15.2.5. Financial Analysis
15.2.6. SWOT Analysis
15.2.7. Business Strategies
15.3. Byram Healthcare
15.3.1. Company Details
15.3.2. Company Overview
15.3.3. Product Offerings
15.3.4. Key Developments
15.3.5. Financial Analysis
15.3.6. SWOT Analysis
15.3.7. Business Strategies
15.4. Danone S.A
15.4.1. Company Details
15.4.2. Company Overview
15.4.3. Product Offerings
15.4.4. Key Developments
15.4.5. Financial Analysis
15.4.6. SWOT Analysis
15.4.7. Business Strategies
15.5. Fresenius Kabi A
15.5.1. Company Details
15.5.2. Company Overview
15.5.3. Product Offerings
15.5.4. Key Developments
15.5.5. Financial Analysis
15.5.6. SWOT Analysis
15.5.7. Business Strategies
15.6. Global Health Products, Inc.
15.6.1. Company Details
15.6.2. Company Overview
15.6.3. Product Offerings
15.6.4. Key Developments
15.6.5. Financial Analysis
15.6.6. SWOT Analysis
15.6.7. Business Strategies
15.7. Hormel Foods, LLC
15.7.1. Company Details
15.7.2. Company Overview
15.7.3. Product Offerings
15.7.4. Key Developments
15.7.5. Financial Analysis
15.7.6. SWOT Analysis
15.7.7. Business Strategies
15.8. HOIL BIOMAED INC.
15.8.1. Company Details
15.8.2. Company Overview
15.8.3. Product Offerings
15.8.4. Key Developments
15.8.5. Financial Analysis
15.8.6. SWOT Analysis
15.8.7. Business Strategies
15.9. Mead Johnson & Company, LLC
15.9.1. Company Details
15.9.2. Company Overview
15.9.3. Product Offerings
15.9.4. Key Developments
15.9.5. Financial Analysis
15.9.6. SWOT Analysis
15.9.7. Business Strategies
15.10. Meiji Holdings Co., Ltd
15.10.1. Company Details
15.10.2. Company Overview
15.10.3. Product Offerings
15.10.4. Key Developments
15.10.5. Financial Analysis
15.10.6. SWOT Analysis
15.10.7. Business Strategies
15.11. Medline Industries Inc
15.11.1.
Company Details
15.11.2.
Company Overview
15.11.3.
Product Offerings
15.11.4.
Key Developments
15.11.5.
Financial Analysis
15.11.6.
SWOT Analysis
15.11.7.
Business Strategies
15.12. Nestlé S.A.
15.12.1.
Company Details
15.12.2.
Company Overview
15.12.3.
Product Offerings
15.12.4.
Key Developments
15.12.5.
Financial Analysis
15.12.6.
SWOT Analysis
15.12.7.
Business Strategies
15.13. Nutritional Medicinals, LLC
15.13.1.
Company Details
15.13.2.
Company Overview
15.13.3.
Product Offerings
15.13.4.
Key Developments
15.13.5.
Financial Analysis
15.13.6.
SWOT Analysis
15.13.7.
Business Strategies
15.14. NUTRICIA
15.14.1.
Company Details
15.14.2.
Company Overview
15.14.3.
Product Offerings
15.14.4.
Key Developments
15.14.5.
Financial Analysis
15.14.6.
SWOT Analysis
15.14.7.
Business Strategies
15.15. Real Food Blends
15.15.1.
Company Details
15.15.2.
Company Overview
15.15.3.
Product Offerings
15.15.4.
Key Developments
15.15.5.
Financial Analysis
15.15.6.
SWOT Analysis
15.15.7.
Business Strategies
15.16. Victus, Inc.
15.16.1.
Company Details
15.16.2.
Company Overview
15.16.3.
Product Offerings
15.16.4.
Key Developments
15.16.5.
Financial Analysis
15.16.6.
SWOT Analysis
15.16.7.
Business Strategies
Note:
This ToC is tentative and can be changed according to the research study
conducted during the course of report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.